Performance Medical Technologies (PMT) is an early-stage biopharmaceutical and clinical data science company on a mission to transform the treatment landscape for neurodegenerative diseases. We are actively seeking visionary investors to join us in funding the development, clinical validation, and regulatory approval of a novel therapy—engineered to slow disease progression in early-stage Parkinson’s Disease and related conditions.
We are developing a first-in-class therapeutic, targeting key mechanisms of neurodegeneration:
PMT’s dual-jurisdiction approach in the U.S. and EU integrates clinical trials, GMP-grade manufacturing, and regulatory compliance into a streamlined path toward FDA and EMA approvals.
Fermentation expert in biologic production
Fermentation expert in biologic production (using different organism).
Regulatory-grade purification and formulation.
Preclinical and clinical pilot study collaboration.
Preclinical and clinical pilot study (using VA Tech biologic).
Investment funds will directly support:
PMT is building a future where early-stage intervention isn’t just possible—it’s standard. By investing now, you become part of a focused, high-impact effort to deliver a disease-modifying therapy to the millions affected by neurodegenerative conditions.
Help us unlock new standards of care through science, data, and global collaboration.
